Clinical features, imaging use, and management in giant cell arteritis: a retrospective single-center study
- 5 September 2024
- journal article
- research article
- Published by Springer Nature in Clinical Rheumatology
- Vol. 43 (11) , 3409-3417
Abstract
This study examines the characteristics of patients with giant cell arteritis (GCA), the utilization of imaging in GCA diagnosis, and variations in GCA management among specialties. Subjects were identified from the Dallas VAMC database spanning 2010 to 2021 using ICD-9/10 codes for GCA and polymyalgia rheumatica, and a list of temporal artery biopsies (TAB). Patients lacking sufficient data to meet the ACR 1990 classification criteria for GCA were excluded. Categorical variables were compared using Fisher’s exact test. Continuous variables were analyzed with the Kruskal–Wallis test. Among 209 identified patients, 41 were excluded due to insufficient data for ACR classification. The cohort comprised 91.9% males with a median age of 69. Of the remaining 168 patients, 42 received a final diagnosis of GCA, and 15 of these were confirmed with a positive TAB. The most reported initial symptoms were visual disturbances (75.5%) and headaches (67.7%). Ophthalmology was the initial physician for 46% of patients. GCA correlated with co-existing autoimmune diseases, glucocorticoid-sparing treatments, and consultation with a rheumatologist (p < 0.05). There were no significant differences in clinical features or management of the positive and negative TAB GCA groups. GCA presents with heterogeneous symptoms making diagnosis challenging. Scalp tenderness and headaches were significantly higher in GCA patients, but sub-group analysis revealed no significant differences among GCA patients. Vascular assessments and adjunct imaging modalities are underutilized. The establishment of multidisciplinary or fast-track clinics may enhance the optimization of GCA management. Key Points • The most common presenting symptoms were blurry vision/visual loss (75.5%), headache (67.7%), and scalp tenderness (35.9%) in descending order. • In sub-group analysis, no significant differences were found between GCA sub-groups, but when compared to the non-GCA group, were found to have significantly higher rates of headache and scalp tenderness. • Compared to other specialties, rheumatologists were more likely to use advanced imaging, and to prescribe glucocorticoid-sparing treatments. • Systematic and comprehensive assessment and multidisciplinary approach could improve diagnosis and management.Keywords
Funding Information
- Office of Academic Affiliations, Department of Veterans Affairs
This publication has 23 references indexed in Scilit:
- Sensitivity of temporal artery biopsy in the diagnosis of giant cell arteritis: a systematic literature review and meta-analysisRheumatology, 2019
- Hyperglycemia and 18F-FDG PET/CT, issues and problem solving: a literature reviewActa Diabetologica, 2019
- Diagnostic performance of temporal artery ultrasound for the diagnosis of giant cell arteritis: a systematic review and meta-analysis of the literatureAutoimmunity Reviews, 2019
- EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practiceAnnals of the Rheumatic Diseases, 2018
- CT analysis of the aorta in giant-cell arteritis: a case-control studyEuropean Radiology, 2018
- Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunitiesNature Reviews Rheumatology, 2017
- Trial of Tocilizumab in Giant-Cell ArteritisNew England Journal of Medicine, 2017
- Newly diagnosed vs. relapsing giant cell arteritis: Baseline data from the GiACTA trialSeminars in Arthritis and Rheumatism, 2017
- The Role of Ultrasound Compared to Biopsy of Temporal Arteries in the Diagnosis and Treatment of Giant Cell Arteritis (TABUL): a diagnostic accuracy and cost-effectiveness studyHealth Technology Assessment, 2016
- Polymyalgia Rheumatica and Giant Cell ArteritisJAMA, 2016